Cetera Investment Advisers - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 375 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cetera Investment Advisers ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2024$978,059
+170.9%
30,258
+374.5%
0.00%
-71.4%
Q4 2020$361,000
+80.5%
6,377
+50.9%
0.01%
-56.2%
Q3 2020$200,000
-23.7%
4,225
-4.9%
0.02%
-33.3%
Q2 2020$262,0004,4450.02%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Bellevue Group AG 9,347,926$313,529,0003.18%
Sicart Associates LLC 291,254$9,769,0002.66%
Camber Capital Management LP 2,500,000$83,850,0002.58%
SECTOR GAMMA AS 263,870$8,850,0001.76%
Parkman Healthcare Partners LLC 136,380$4,574,0001.16%
Eversept Partners, LP 450,501$15,109,8041.05%
SPHERA FUNDS MANAGEMENT LTD. 350,000$11,739,0000.99%
TANAKA CAPITAL MANAGEMENT INC 16,661$559,0000.80%
Sonora Investment Management, LLC 163,703$5,491,0000.69%
ARK Investment Management 8,511,384$285,472,0000.69%
View complete list of IONIS PHARMACEUTICALS INC shareholders